Platinum containing anticancer drugs include cisplatin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells HeLa Cells Cell Line Kidney HT29 Cells MCF-7 Cells KB Cells Hep G2 Cells HL-60 Cells K562 Cells Mitochondria

Organisms4

Mice, Nude Mice, Inbred BALB C Taxus Mice, SCID

Diseases35

Neoplasms Ovarian Neoplasms Lung Neoplasms Carcinoma, Non-Small-Cell Lung Leukemia L1210 Head and Neck Neoplasms Carcinoma, Squamous Cell Adenocarcinoma Neoplasms, Glandular and Epithelial Vomiting Breast Neoplasms Leukopenia Colonic Neoplasms Leukemia P388 Carcinoma, Small Cell Stomach Neoplasms Carcinoma Neoplasms, Experimental Nausea Testicular Neoplasms Neutropenia Neoplasm Recurrence, Local Osteosarcoma Neoplasm Metastasis Mesothelioma Neoplasms, Germ Cell and Embryonal Thrombocytopenia Liver Neoplasms Peritoneal Neoplasms Uterine Cervical Neoplasms Pleural Neoplasms Intracranial Aneurysm Melanoma Esophageal Neoplasms Melanoma, Experimental

Chemicals and Drugs110

Cisplatin Platinum Compounds Antineoplastic Agents Organoplatinum Compounds Carboplatin Doxorubicin DNA Adducts Paclitaxel Platinum Antineoplastic Agents, Phytogenic Etoposide Antibiotics, Antineoplastic Fluorouracil Camptothecin Drug Carriers Vinblastine Deoxycytidine Taxoids Coordination Complexes Mitomycin Ellipticines P-Glycoprotein DNA Antimetabolites, Antineoplastic Cross-Linking Reagents Bleomycin Prodrugs Tumor Suppressor Protein p53 Enzyme Inhibitors Ifosfamide Intercalating Agents Nanocapsules DNA Topoisomerases, Type II Topoisomerase I Inhibitors Caspases Cyclohexylamines Antineoplastic Agents, Alkylating Glutathione DNA, Neoplasm Multidrug Resistance-Associated Proteins Proto-Oncogene Proteins c-bcl-2 Chloroacetates Caspase 3 Guanine Plant Extracts Radiation-Sensitizing Agents Neoplasm Proteins Daunorubicin Palladium Vincristine Liposomes RNA, Small Interfering Topotecan DNA Topoisomerases, Type I DNA-Binding Proteins Tegafur Mitoxantrone Methotrexate Poly(ADP-ribose) Polymerases Cyclophosphamide ATP-Binding Cassette Transporters Epirubicin RNA, Messenger Triazines Topoisomerase II Inhibitors Drugs, Investigational Topoisomerase Inhibitors Endonucleases Teniposide Polyethylene Glycols Oxonic Acid Xanthones Dioxoles Adjuvants, Pharmaceutic Buthionine Sulfoximine Reactive Oxygen Species Mitomycins Tetrazolium Salts Tubulin Modulators Organometallic Compounds Anthracyclines Amifostine Anticarcinogenic Agents Vindesine Drug Combinations Rhodium bcl-2-Associated X Protein Tetrahydroisoquinolines Bridged Compounds Pyrazines Piperazines Vinca Alkaloids Floxuridine Razoxane Polymers Podophyllotoxin Ruthenium Aziridines Indazoles Boronic Acids Benzoquinones Histone Deacetylase Inhibitors Protein Kinase Inhibitors Carmustine Indoles Glutathione Transferase Triterpenes Micelles Quinazolines Nimustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment48

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Drug Delivery Systems Drug Carriers Inhibitory Concentration 50 Drug Administration Schedule Xenograft Model Antitumor Assays Combined Modality Therapy Treatment Outcome Drug Design Survival Analysis Nanocapsules Drug Evaluation, Preclinical Infusions, Intravenous Disease-Free Survival Drug Evaluation Neoplasm Transplantation Blotting, Western Survival Rate Neoplasms, Experimental Neoplasm Staging Drug Discovery Transplantation, Heterologous Embolization, Therapeutic Flow Cytometry Clinical Trials as Topic Tumor Stem Cell Assay Maximum Tolerated Dose Transfection Molecular Targeted Therapy Spectrophotometry, Atomic Models, Molecular Clinical Trials, Phase I as Topic Area Under Curve Administration, Oral Models, Biological Hyperthermia, Induced Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Tumor Burden Prognosis Phytotherapy Salvage Therapy Magnetic Resonance Spectroscopy Gene Knockdown Techniques Melanoma, Experimental Metabolic Clearance Rate Electrochemotherapy

Phenomena and Processes44

Drug Resistance, Neoplasm DNA Adducts Apoptosis Cell Survival Dose-Response Relationship, Drug Drug Synergism Inhibitory Concentration 50 DNA Damage Cell Proliferation Drug Resistance Molecular Structure Drug Resistance, Multiple Cell Cycle DNA Repair Gene Expression Regulation, Neoplastic Time Factors Structure-Activity Relationship Signal Transduction Cell Division Cell Death Drug Interactions Maximum Tolerated Dose Down-Regulation Transfection Particle Size Base Sequence Genes, MDR Kinetics Cell Cycle Checkpoints Area Under Curve Stereoisomerism Enzyme Activation Molecular Conformation Phosphorylation Nucleic Acid Conformation RNA Interference Up-Regulation Tissue Distribution Protein Binding Mutation Metabolic Clearance Rate DNA Fragmentation G2 Phase Binding Sites

Disciplines and Occupations5

Drug Design Nanomedicine Drug Discovery Pharmacogenetics Nanotechnology

Technology, Industry, Agriculture9

Nanoparticles Nanomedicine Nanocapsules Liposomes Polyethylene Glycols Metal Nanoparticles Nanostructures Polymers Nanotechnology

Information Science3

Survival Rate Base Sequence Molecular Sequence Data

Health Care7

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Clinical Trials as Topic Clinical Trials, Phase I as Topic Area Under Curve

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Cisplatin Platinum Compounds Antineoplastic Agents Drug Screening Assays, Antitumor Organoplatinum Compounds Cell Line, Tumor Drug Resistance, Neoplasm Antineoplastic Combined Chemotherapy Protocols Neoplasms Carboplatin Doxorubicin Ovarian Neoplasms DNA Adducts Apoptosis Paclitaxel Platinum Antineoplastic Agents, Phytogenic Etoposide Cell Survival Tumor Cells, Cultured Lung Neoplasms Antibiotics, Antineoplastic Dose-Response Relationship, Drug Drug Synergism Fluorouracil Camptothecin Drug Delivery Systems Drug Carriers Inhibitory Concentration 50 Vinblastine Deoxycytidine Drug Administration Schedule Xenograft Model Antitumor Assays Mice, Nude DNA Damage Taxoids Cell Proliferation Coordination Complexes Drug Resistance Combined Modality Therapy Treatment Outcome Molecular Structure Mitomycin Carcinoma, Non-Small-Cell Lung Drug Resistance, Multiple Ellipticines P-Glycoprotein DNA Cell Cycle DNA Repair Leukemia L1210 Gene Expression Regulation, Neoplastic Head and Neck Neoplasms Antimetabolites, Antineoplastic Carcinoma, Squamous Cell Cross-Linking Reagents Adenocarcinoma Drug Design Bleomycin Prodrugs Survival Analysis Tumor Suppressor Protein p53 Nanoparticles Enzyme Inhibitors Ifosfamide Intercalating Agents Nanomedicine Nanocapsules Drug Evaluation, Preclinical Infusions, Intravenous DNA Topoisomerases, Type II Topoisomerase I Inhibitors Disease-Free Survival Caspases Time Factors Cyclohexylamines Neoplasms, Glandular and Epithelial Drug Evaluation Vomiting Antineoplastic Agents, Alkylating Breast Neoplasms Leukopenia Colonic Neoplasms Glutathione DNA, Neoplasm Multidrug Resistance-Associated Proteins Proto-Oncogene Proteins c-bcl-2 Chloroacetates Caspase 3 Guanine Plant Extracts Radiation-Sensitizing Agents Neoplasm Proteins Daunorubicin Neoplasm Transplantation Structure-Activity Relationship Leukemia P388 Blotting, Western Survival Rate Signal Transduction

No FAQ available that match "platinum containing anticancer drugs include cisplatin"